PRIYANKA SAIGAL: Open Payments
NPI 1023491438 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 59 payments from 19 companies in 2025. Trend: 2023 $1,903 · 2024 $1,125 · 2025 $1,425
Food & beverage: $1,425
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $266 |
| Neurocrine BioSciences, Inc. | 5 | $125 |
| Alkermes, Inc. | 5 | $117 |
| Almatica Pharma LLC | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 4 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Bausch Health US, LLC | 3 | $55 |
Products named: Auvelity, REXULTI, INGREZZA, LOREEV XR, COBENFY, CAPLYTA, LYBALVI, HETLIOZ.
Industry payments across FL — which companies pay providers there.
